BACKGROUND: Nitric oxide (NO) is a compound with both protective and damaging effects on neurons. Quantification of NO metabolites in humans is limited by sample contamination with blood. In vivo cerebral microdialysis may offer an alternative approach as sampling of extracellular fluid (ECF) adjacent to neurons becomes possible. We investigate the prognostic value of brain ECF NO metabolites in patients with traumatic brain injury (TBI). METHODS: A prospective case cohort of 195 ECF samples collected from 11 cases over 4 days following TBI was collected. Nitrate and nitrite concentrations ([NO x ]) were quantified using a vanadium-based colorimetric assay. RESULTS: Early ECF [NO x ] (<48 h post TBI) were significantly higher in non-survivors (median 59.2 μmol/l, n = 7) compared to survivors (23.3 μmol/l, n = 4) (P = 0.04). Late (48-96 h) ECF [NO x ] remained higher in non-survivors (47.9 μmol/l) compared to survivors (23.0 μmol/l) but this was not significant (P = 0.29). Receiver operator characteristic analysis shows an optimized cutoff level for ECF [NO x ] of 26.5 μmol/l measured <48 h post TBI for predicting non-survival (sensitivity 100%, specificity 75%). CONCLUSION: Early ECF NO x concentrations are of prognostic value after TBI. ECF NO x may be a useful biomarker for treatment trials targeted at nitric oxide metabolism.
BACKGROUND: Nitric oxide (NO) is a compound with both protective and damaging effects on neurons. Quantification of NO metabolites in humans is limited by sample contamination with blood. In vivo cerebral microdialysis may offer an alternative approach as sampling of extracellular fluid (ECF) adjacent to neurons becomes possible. We investigate the prognostic value of brain ECF NO metabolites in patients with traumatic brain injury (TBI). METHODS: A prospective case cohort of 195 ECF samples collected from 11 cases over 4 days following TBI was collected. Nitrate and nitrite concentrations ([NO x ]) were quantified using a vanadium-based colorimetric assay. RESULTS: Early ECF [NO x ] (<48 h post TBI) were significantly higher in non-survivors (median 59.2 μmol/l, n = 7) compared to survivors (23.3 μmol/l, n = 4) (P = 0.04). Late (48-96 h) ECF [NO x ] remained higher in non-survivors (47.9 μmol/l) compared to survivors (23.0 μmol/l) but this was not significant (P = 0.29). Receiver operator characteristic analysis shows an optimized cutoff level for ECF [NO x ] of 26.5 μmol/l measured <48 h post TBI for predicting non-survival (sensitivity 100%, specificity 75%). CONCLUSION: Early ECF NO x concentrations are of prognostic value after TBI. ECF NO x may be a useful biomarker for treatment trials targeted at nitric oxide metabolism.
Authors: R S Clark; P M Kochanek; W D Obrist; H R Wong; T R Billiar; S R Wisniewski; D W Marion Journal: Crit Care Med Date: 1996-07 Impact factor: 7.598
Authors: Konrad Rejdak; Axel Petzold; Martyn A Sharpe; Andrew D Kay; Mary Kerr; Geoff Keir; Edward J Thompson; Gavin Giovannoni Journal: J Neurol Sci Date: 2004-04-15 Impact factor: 3.181
Authors: Axel Petzold; Martin M Tisdall; Armand R Girbes; Lillian Martinian; Maria Thom; Neil Kitchen; Martin Smith Journal: Brain Date: 2011-02 Impact factor: 13.501
Authors: Bo-Michael Bellander; Emmanuel Cantais; Per Enblad; Peter Hutchinson; Carl-Henrik Nordström; Claudia Robertson; Juan Sahuquillo; Martin Smith; Nino Stocchetti; Urban Ungerstedt; Andreas Unterberg; Niels Vidiendal Olsen Journal: Intensive Care Med Date: 2004-11-10 Impact factor: 17.440
Authors: Ayesha Imam; Guang Jin; Martin Sillesen; Simone E Dekker; Ted Bambakidis; John O Hwabejire; Cecilie H Jepsen; Ihab Halaweish; Hasan B Alam Journal: J Neurotrauma Date: 2014-12-19 Impact factor: 5.269
Authors: Jens Bak Sommer; Anders Bach; Hana Malá; Mikko Gynther; Ann-Sofie Bjerre; Marie Gajhede Gram; Linda Marschner; Kristian Strømgaard; Jesper Mogensen; Darryl S Pickering Journal: Neurochem Res Date: 2017-08-21 Impact factor: 3.996